Helpers of the cellular gatekeeper-miRNAs dance in P53 network

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1805, Issue 2, 2010, Pages 218-225

  Shi, Ming ^a   Liu, Dan ^b   Shen, Beifen ^a   Guo, Ning ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell proliferation; MicroRNA; Oncogene; p53; Tumor suppresser

Indexed keywords

DIHYDROFOLATE REDUCTASE; DNA METHYLTRANSFERASE 3A; INSULIN RECEPTOR SUBSTRATE 1; K RAS PROTEIN; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 7; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN P53; SIRTUIN 1; TRANSCRIPTION FACTOR SOX2; WNT3A PROTEIN;

CANCER STEM CELL; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RNA PROCESSING; RNA STABILITY; RNA TRANSLATION; TUMOR SUPPRESSOR GENE;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; TUMOR SUPPRESSOR PROTEIN P53;

PYRONIA TITHONUS;

EID: 77649336025     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2009.12.001     Document Type: Review

References (128)

1. Linzer D.I., and Levine A.J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17 (1979) 43-52
2. Lane D.P., and Crawford L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature 278 (1979) 261-263
3. DeLeo A.B., Jay G., Appella E., Dubois G.C., Law L.W., and Old L.J. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 2420-2424
4. Baker S.J., Fearon E.R., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., vanTuinen P., Ledbetter D.H., Barker D.F., Nakamura Y., White R., and Vogelstein B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244 (1989) 217-221
5. Finlay C.A., Hinds P.W., and Levine A.J. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57 (1989) 1083-1093
6. Sinha A.U., Kaimal V., Chen J., and Jegga A.G. Dissecting microregulation of a master regulatory network. BMC Genomics 9 (2008) 88
7. Batchelor E., Loewer A., and Lahav G. The ups and downs of p53: understanding protein dynamics in single cells. Nat. Rev. Cancer 9 (2009) 371-377
8. Xi Y., Shalgi R., Fodstad O., Pilpel Y., and Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin. Cancer Res. 12 (2006) 2014-2024
9. Shin S., Cha H.J., Lee E.M., Jung J.H., Lee S.J., Park I.C., Jin Y.W., and An S. MicroRNAs are significantly influenced by p53 and radiation in HCT116 human colon carcinoma cells. Int. J. Oncol. 34 (2009) 1645-1652
10. Hosako H., Martin G.S., Barrier M., Chen Y.A., Ivanov I.V., and Mirkes P.E. Gene and microRNA expression in p53-deficient day 8.5 mouse embryos. Birth Defects Res. A Clin. Mol. Teratol. 85 (2009) 546-555
11. Flavin R.J., Smyth P.C., Laios A., O'Toole S.A., Barrett C., Finn S.P., Russell S., Ring M., Denning K.M., Li J., Aherne S.T., Sammarae D.A., Aziz N.A., Alhadi A., Sheppard B.L., Lao K., Sheils O.M., and O'Leary J.J. Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma. Mod. Pathol. 22 (2009) 197-205
12. Xi Y., Formentini A., Chien M., Weir D.B., Russo J.J., Ju J., Kornmann M., and Ju J. Prognostic values of microRNAs in colorectal cancer. Biomark. Insights 2 (2006) 113-121
13. Braun C.J., Zhang X., Savelyeva I., Wolff S., Moll U.M., Schepeler T., Orntoft T.F., Andersen C.L., and Dobbelstein M. p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 68 (2008) 10094-10104
14. Mraz M., Malinova K., Kotaskova J., Pavlova S., Tichy B., Malcikova J., Stano Kozubik K., Smardova J., Brychtova Y., Doubek M., Trbusek M., Mayer J., and Pospisilova S. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 23 (2009) 1159-1163
15. He L., He X., Lowe S.W., and Hannon G.J. microRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat. Rev. Cancer 7 (2007) 819-822
16. Hermeking H. p53 enters the microRNA world. Cancer Cell 12 (2007) 414-418
17. Beckman M. MicroRNAs found cavorting with p53. J. Natl. Cancer Inst. 99 (2007) 1664-1665
18. He X., He L., and Hannon G.J. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 67 (2007) 11099-11101
19. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., Shahab A., Yong H.C., Fu Y., Weng Z., Liu J., Zhao X.D., Chew J.L., Lee Y.L., Kuznetsov V.A., Sung W.K., Miller L.D., Lim B., Liu E.T., Yu Q., Ng H.H., and Ruan Y. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 (2006) 207-219
20. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., MacDougald O.A., Cho K.R., and Fearon E.R. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17 (2007) 1298-1307
21. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S., Chen C., Lowe S.W., Cleary M.A., and Hannon G.J. A microRNA component of the p53 tumour suppressor network. Nature 447 (2007) 1130-1134
22. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., and Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26 (2007) 731-743
23. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., and Nikitin A.Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 67 (2007) 8433-8438
24. Kato M., Paranjape T., Ullrich R., Nallur S., Gillespie E., Keane K., Esquela-Kerscher A., Weidhaas J.B., and Slack F.J. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28 (2009) 2419-2424
25. Georges S.A., Chau B.N., Braun C.J., Zhang X., and Dobbelstein M. Cell cycle arrest or apoptosis by p53: are microRNAs-192/215 and -34 making the decision?. Cell. Cycle 8 (2009) 680-681
26. Georges S.A., Biery M.C., Kim S.Y., Schelter J.M., Guo J., Chang A.N., Jackson A.L., Carleton M.O., Linsley P.S., Cleary M.A., and Chau B.N. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res. 68 (2008) 10105-10112
27. Wang X., Wang H.K., McCoy J.P., Banerjee N.S., Rader J.S., Broker T.R., Meyers C., Chow L.T., Zheng Z.M., and Oncogenic H.P.V. infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15 (2009) 637-647
28. Pogribny I.P., Muskhelishvili L., Tryndyak V.P., and Beland F.A. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol. Appl. Pharmacol. 235 (2009) 305-311
29. Cohen M.B., and Rokhlin O.W. Mechanisms of prostate cancer cell survival after inhibition of AR expression. J. Cell. Biochem. 106 (2009) 363-371
30. Fujita Y., Kojima K., Hamada N., Ohhashi R., Akao Y., Nozawa Y., Deguchi T., and Ito M. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem. Biophys. Res. Commun. 377 (2008) 114-119
31. Zenz T., Mohr J., Eldering E., Kater A.P., Buhler A., Kienle D., Winkler D., Durig J., van Oers M.H., Mertens D., Dohner H., and Stilgenbauer S. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 113 (2009) 3801-3808
32. Ji Q., Hao X., Zhang M., Tang W., Yang M., Li L., Xiang D., Desano J.T., Bommer G.T., Fan D., Fearon E.R., Lawrence T.S., and Xu L. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 4 (2009) e6816
33. Ji Q., Hao X., Meng Y., Zhang M., Desano J., Fan D., and Xu L. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8 (2008) 266
34. Hermeking H. The miR-34 family in cancer and apoptosis. Cell. Death Differ 22 (2009) 22
35. Hermeking H. MiR-34a and p53. Cell. Cycle 8 (2009) 1308
36. Song B., Wang Y., Kudo K., Gavin E.J., Xi Y., and Ju J. miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin. Cancer Res. 14 (2008) 8080-8086
37. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., Elble R., Watabe K., and Mo Y.Y. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 3207-3212
38. Ho J.S., Ma W., Mao D.Y., and Benchimol S. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol. Cell. Biol. 25 (2005) 7423-7431
39. Green D.R., and Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 458 (2009) 1127-1130
40. Toledo F., and Bardot B. Cancer: three birds with one stone. Nature 460 (2009) 466-467
41. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., and Miyazono K. Modulation of microRNA processing by p53. Nature 460 (2009) 529-533
42. Kruse J.P., and Gu W. Modes of p53 regulation. Cell 137 (2009) 609-622
43. Mudhasani R., Zhu Z., Hutvagner G., Eischen C.M., Lyle S., Hall L.L., Lawrence J.B., Imbalzano A.N., and Jones S.N. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J. Cell. Biol. 181 (2008) 1055-1063
44. Le M.T., Teh C., Shyh-Chang N., Xie H., Zhou B., Korzh V., Lodish H.F., and Lim B. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23 (2009) 862-876
45. Carter S., and Vousden K.H. Modifications of p53: competing for the lysines. Curr. Opin. Genet. Dev. 19 (2009) 18-24
46. Fornari, Gramantieri, Giovannini, Veronese A., Ferracin M., Sabbioni S., Calin G.A., Grazi G.L., Croce C.M., Tavolari S., Chieco P., Negrini M., and Bolondi L. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 69 (2009) 5761-5767
47. Kwon S.H., Park J.C., Ramachandran S., Cha S.D., Kwon K.Y., Park J.K., Park J.W., Bae I., and Cho C.H. Loss of cyclin g1 expression in human uterine leiomyoma cells induces apoptosis. Reprod. Sci. 15 (2008) 400-410
48. Yamakuchi M., Ferlito M., and Lowenstein C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 13421-13426
49. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., and Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107 (2001) 137-148
50. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., and Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107 (2001) 149-159
51. Yamakuchi M., and Lowenstein C.J. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8 (2009) 712-715
52. Zuckerman V., Wolyniec K., Sionov R.V., Haupt S., and Haupt Y. Tumour suppression by p53: the importance of apoptosis and cellular senescence. J. Pathol. 219 (2009) 3-15
53. Collado M., Blasco M.A., and Serrano M. Cellular senescence in cancer and aging. Cell 130 (2007) 223-233
54. Halazonetis T.D., Gorgoulis V.G., and Bartek J. An oncogene-induced DNA damage model for cancer development. Science 319 (2008) 1352-1355
55. Campisi J. Suppressing cancer: the importance of being senescent. Science 309 (2005) 886-887
56. Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., and Lane D.P. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 19 (2005) 2122-2137
57. Chen J., Ng S.M., Chang C., Zhang Z., Bourdon J.C., Lane D.P., and Peng J. p53 isoform delta113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish. Genes Dev. 23 (2009) 278-290
58. Fujita K., Mondal A.M., Horikawa I., Nguyen G.H., Kumamoto K., Sohn J.J., Bowman E.D., Mathe E.A., Schetter A.J., Pine S.R., Ji H., Vojtesek B., Bourdon J.C., Lane D.P., and Harris C.C. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat. Cell Biol. 11 (2009) 1135-1142
59. Park S.Y., Lee J.H., Ha M., Nam J.W., and Kim V.N. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol 16 (2009) 23-29
60. Hennessy B.T., Smith D.L., Ram P.T., Lu Y., and Mills G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4 (2005) 988-1004
61. Mayo L.D., and Donner D.B. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem. Sci. 27 (2002) 462-467
62. Papagiannakopoulos T., Shapiro A., and Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 68 (2008) 8164-8172
63. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., and Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283 (2008) 1026-1033
64. Voorhoeve P.M., le Sage C., Schrier M., Gillis A.J., Stoop H., Nagel R., Liu Y.P., van Duijse J., Drost J., Griekspoor A., Zlotorynski E., Yabuta N., De Vita G., Nojima H., Looijenga L.H., and Agami R. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124 (2006) 1169-1181
65. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., Egan D.A., Li A., Huang G., Klein-Szanto A.J., Gimotty P.A., Katsaros D., Coukos G., Zhang L., Pure E., and Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell. Biol. 10 (2008) 202-210
66. Li Y., Pei J., Xia H., Ke H., Wang H., and Tao W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22 (2003) 4398-4405
67. Lee K.H., Goan Y.G., Hsiao M., Lee C.H., Jian S.H., Lin J.T., Chen Y.L., and Lu P.J. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp. Cell Res. 315 (2009) 2529-2538
68. Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H., and Oren M. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20 (2006) 2687-2700
69. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., Enright A.J., Dougan G., Turner M., and Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 316 (2007) 608-611
70. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., Schmidt-Supprian M., Rajewsky N., Yancopoulos G., Rao A., and Rajewsky K. Regulation of the germinal center response by microRNA-155. Science 316 (2007) 604-608
71. Dorsett Y., McBride K.M., Jankovic M., Gazumyan A., Thai T.H., Robbiani D.F., Di Virgilio M., San-Martin B.R., Heidkamp G., Schwickert T.A., Eisenreich T., Rajewsky K., and Nussenzweig M.C. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28 (2008) 630-638
72. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., and Papavasiliou F.N. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28 (2008) 621-629
73. Ceppi M., Pereira P.M., Dunand-Sauthier I., Barras E., Reith W., Santos M.A., and Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 2735-2740
74. O'Connell R.M., Rao D.S., Chaudhuri A.A., Boldin M.P., Taganov K.D., Nicoll J., Paquette R.L., and Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205 (2008) 585-594
75. Kong W., Yang H., He L., Zhao J.J., Coppola D., Dalton W.S., and Cheng J.Q. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28 (2008) 6773-6784
76. Yoshida K., Liu H., and Miki Y. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J. Biol. Chem. 281 (2006) 5734-5740
77. Tomasini R., Samir A.A., Carrier A., Isnardon D., Cecchinelli B., Soddu S., Malissen B., Dagorn J.C., Iovanna J.L., and Dusetti N.J. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J. Biol. Chem. 278 (2003) 37722-37729
78. Gironella M., Seux M., Xie M.J., Cano C., Tomasini R., Gommeaux J., Garcia S., Nowak J., Yeung M.L., Jeang K.T., Chaix A., Fazli L., Motoo Y., Wang Q., Rocchi P., Russo A., Gleave M., Dagorn J.C., Iovanna J.L., Carrier A., Pebusque M.J., and Dusetti N.J. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 16170-16175
79. Yu J., and Zhang L. PUMA, a potent killer with or without p53. Oncogene 27 Suppl 1 (2008) S71-S83
80. Choy E.Y., Siu K.L., Kok K.H., Lung R.W., Tsang C.M., To K.F., Kwong D.L., Tsao S.W., and Jin D.Y. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 205 (2008) 2551-2560
81. Pfeffer S., Zavolan M., Grasser F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., and Tuschl T. Identification of virus-encoded microRNAs. Science 304 (2004) 734-736
82. Vousden K.H., and Prives C. Blinded by the light: the growing complexity of p53. Cell 137 (2009) 413-431
83. Aranha M.M., Sola S., Low W.C., Steer C.J., and Rodrigues C.M. Caspases and p53 modulate FOXO3A/Id1 signaling during mouse neural stem cell differentiation. J. Cell. Biochem. 107 (2009) 748-758
84. Flores I., and Blasco M.A. A p53-dependent response limits epidermal stem cell functionality and organismal size in mice with short telomeres. PLoS One 4 (2009) e4934
85. Stecca B., and Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J. 28 (2009) 663-676
86. Liu Y., Elf S.E., Miyata Y., Sashida G., Liu Y., Huang G., Di Giandomenico S., Lee J.M., Deblasio A., Menendez S., Antipin J., Reva B., Koff A., and Nimer S.D. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4 (2009) 37-48
87. Zheng H., Ying H., Yan H., Kimmelman A.C., Hiller D.J., Chen A.J., Perry S.R., Tonon G., Chu G.C., Ding Z., Stommel J.M., Dunn K.L., Wiedemeyer R., You M.J., Brennan C., Wang Y.A., Ligon K.L., Wong W.H., Chin L., and DePinho R.A. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455 (2008) 1129-1133
88. Gangaraju V.K., and Lin H. MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10 (2009) 116-125
89. Wang Y., and Blelloch R. Cell cycle regulation by microRNAs in embryonic stem cells. Cancer Res. 69 (2009) 4093-4096
90. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., and Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460 (2009) 705-710
91. Yoo A.S., Staahl B.T., Chen L., and Crabtree G.R. MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature 460 (2009) 642-646
92. Tay Y., Zhang J., Thomson A.M., Lim B., and Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455 (2008) 1124-1128
93. Singh S.K., Kagalwala M.N., Parker-Thornburg J., Adams H., and Majumder S. REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 453 (2008) 223-227
94. Buckley N.J., Johnson R., Sun Y.M., and Stanton L.W. Is REST a regulator of pluripotency?. Nature 457 (2009) E5-E6 discussion E7
95. Schwamborn J.C., Berezikov E., and Knoblich J.A. The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 136 (2009) 913-925
96. Nishino J., Kim I., Chada K., and Morrison S.J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 135 (2008) 227-239
97. Marson A., Levine S.S., Cole M.F., Frampton G.M., Brambrink T., Johnstone S., Guenther M.G., Johnston W.K., Wernig M., Newman J., Calabrese J.M., Dennis L.M., Volkert T.L., Gupta S., Love J., Hannett N., Sharp P.A., Bartel D.P., Jaenisch R., and Young R.A. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134 (2008) 521-533
98. Nicoloso M.S., Spizzo R., Shimizu M., Rossi S., and Calin G.A. MicroRNAs-the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9 (2009) 293-302
99. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., and Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (2007) 1109-1123
100. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K., and Clarke M.F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138 (2009) 592-603
101. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., and Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137 (2009) 647-658
102. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
103. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
104. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
105. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., Stadtfeld M., Yachechko R., Tchieu J., Jaenisch R., Plath K., and Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 (2007) 55-70
106. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
107. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., and Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
108. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., and Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 (2008) 141-146
109. Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T., and Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 2883-2888
110. Marion R.M., Strati K., Li H., Murga M., Blanco R., Ortega S., Fernandez-Capetillo O., Serrano M., and Blasco M.A. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460 (2009) 1149-1153
111. Utikal J., Polo J.M., Stadtfeld M., Maherali N., Kulalert W., Walsh R.M., Khalil A., Rheinwald J.G., and Hochedlinger K. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460 (2009) 1145-1148
112. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., Okita K., and Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460 (2009) 1132-1135
113. Li H., Collado M., Villasante A., Strati K., Ortega S., Canamero M., Blasco M.A., and Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460 (2009) 1136-1139
114. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B., Raya A., Wahl G.M., and Belmonte J.C. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460 (2009) 1140-1144
115. Masui S., Nakatake Y., Toyooka Y., Shimosato D., Yagi R., Takahashi K., Okochi H., Okuda A., Matoba R., Sharov A.A., Ko M.S., and Niwa H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9 (2007) 625-635
116. Kim J.B., Sebastiano V., Wu G., Arauzo-Bravo M.J., Sasse P., Gentile L., Ko K., Ruau D., Ehrich M., van den Boom D., Meyer J., Hubner K., Bernemann C., Ortmeier C., Zenke M., Fleischmann B.K., Zaehres H., and Scholer H.R. Oct4-induced pluripotency in adult neural stem cells. Cell 136 (2009) 411-419
117. Yamanaka S. A fresh look at iPS cells. Cell 137 (2009) 13-17
118. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., and Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (2005) 685-689
119. Horwich M.D., and Zamore P.D. Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells. Nat. Protoc. 3 (2008) 1537-1549
120. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
121. Wightman B., Ha I., and Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993) 855-862
122. Wickens M., and Takayama K. RNA. Deviants-or emissaries. Nature 367 (1994) 17-18
123. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
124. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., Hayward D.C., Ball E.E., Degnan B., Muller P., Spring J., Srinivasan A., Fishman M., Finnerty J., Corbo J., Levine M., Leahy P., Davidson E., and Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 (2000) 86-89
125. Slack F.J., Basson M., Liu Z., Ambros V., Horvitz H.R., and Ruvkun G. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor. Mol. Cell 5 (2000) 659-669
126. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 136 (2009) 215-233
127. Kim V.N., Han J., and Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10 (2009) 126-139
128. Carthew R.W., and Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 136 (2009) 642-655